Physiological Variation of Serum Prostate Specific Antigen in the 4.0 to 10.0 ng./ml. Range in Male Volunteers-Reference-Cited by-同舟云学术

Physiological Variation of Serum Prostate Specific Antigen in the 4.0 to 10.0 ng./ml. Range in Male Volunteers

Published:1996-06 Issue:6 Volume:155 Page:1977-1980
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Prestigiacomo Anthony F.¹,Stamey Thomas A.¹

Affiliation:

1. From the Department of Urology, Stanford University School of Medicine, Stanford, California.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference4 articles.

1. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease;Carter;J.A.M.A.,1992

2. Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume;Schmid;Cancer,1993

3. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men;Catalona;J. Urol.,1994

4. Variation of serum prostate specific antigen in 814 men from a screening population: intra-individual assay variation is greater than the repeat assay variation;Komatsu;J. Urol.,1994

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism;Frontiers in Oncology;2022-03-14

2. Effects of cycling and rowing on serum concentrations of prostate‐specific antigen: A randomized study of 101 male subjects;The Prostate;2022-02-22

3. Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer;Journal of Contemporary Brachytherapy;2022

4. Recent advances in graphene-based nanobiosensors for salivary biomarker detection;Biosensors and Bioelectronics;2021-01

5. Good prognosis following a PSA bounce after high dose rate brachytherapy and external radiotherapy in prostate cancer;Radiotherapy and Oncology;2018-12